Recent News

By Region: North America

New study sheds light on how Salmonella spreads in the body

(EurekAlert) Findings of Cambridge scientists, published today in the journal PLoS Pathogens, show a new mechanism used by bacteria to spread in the body with the potential to identify targets to prevent the dissemination of the infection process. Salmonella enterica is a major threat to public health, causing systemic diseases (typhoid and paratyphoid fever), gastroenteritis  Read More »

Proposed H5N1 Research Reviews Raise Concerns

(Science Mag) Researchers are giving a mixed reception to a draft U.S. government plan to do more stringent funding reviews of certain kinds of H5N1 avian influenza research—and perhaps even require some studies to be kept secret. The proposal, presented last week at a meeting of the National Science Advisory Board for Biosecurity, is the  Read More »

Kenya bans importation of all GMO foods

(Digital Journal) In a groundbreaking act, Public Health Minister Beth Mugo of the Kenyan government has advised that Kenya has completely banned the importation of all genetically modified (GMO) food into the country, until exhaustive tests on health effects are complete. Stressing that the decision was taken from genuine concern for Kenyans’ health, the move  Read More »

Suspect powder at Italy ministry sparks false alarm

(Chicago Tribune) Seven people were taken to hospital for checks after a suspect package at Italy’s labor ministry containing powder raised fears of possible anthrax contamination, but the parcel was found to be harmless. A ministry spokesman confirmed it was a false alarm after officials inspected the package at the offices in central Rome. Activists  Read More »

National Institute of Health Awards Contract to Support Use of iBio’s Proprietary Technology for Improved Anthrax Vaccine

(Sacramento Bee) In October 2012, iBio announced issuance of a U.S. patent covering compositions of matter and methods of producing anthrax vaccines, an expansion of the Company’s portfolio of assets relevant to bio-defense and infectious disease product applications. Data previously published in peer-reviewed scientific journals demonstrated the effectiveness of the iBioLaunch platform for development and  Read More »